275 related articles for article (PubMed ID: 11231710)
1. Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza.
Nichol KL
Arch Intern Med; 2001 Mar; 161(5):749-59. PubMed ID: 11231710
[TBL] [Abstract][Full Text] [Related]
2. Seasonal influenza vaccination of healthy working-age adults: a review of economic evaluations.
Gatwood J; Meltzer MI; Messonnier M; Ortega-Sanchez IR; Balkrishnan R; Prosser LA
Drugs; 2012 Jan; 72(1):35-48. PubMed ID: 22191794
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial.
Bridges CB; Thompson WW; Meltzer MI; Reeve GR; Talamonti WJ; Cox NJ; Lilac HA; Hall H; Klimov A; Fukuda K
JAMA; 2000 Oct; 284(13):1655-63. PubMed ID: 11015795
[TBL] [Abstract][Full Text] [Related]
4. Potential cost savings attributable to influenza vaccination of school-aged children.
White T; Lavoie S; Nettleman MD
Pediatrics; 1999 Jun; 103(6):e73. PubMed ID: 10353970
[TBL] [Abstract][Full Text] [Related]
5. Scenarios on costs and savings of influenza treatment and prevention for Dutch healthy working adults.
Postma MJ; Jansema P; Scheijbeler HW; van Genugten ML
Vaccine; 2005 Nov; 23(46-47):5365-71. PubMed ID: 16029916
[TBL] [Abstract][Full Text] [Related]
6. Pharmacoeconomics of influenza vaccination for healthy working adults: reviewing the available evidence.
Postma MJ; Jansema P; van Genugten ML; Heijnen ML; Jager JC; de Jong-van den Berg LT
Drugs; 2002; 62(7):1013-24. PubMed ID: 11985488
[TBL] [Abstract][Full Text] [Related]
7. Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine.
Nichol KL; Mallon KP; Mendelman PM
Vaccine; 2003 May; 21(17-18):2207-17. PubMed ID: 12706712
[TBL] [Abstract][Full Text] [Related]
8. Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis.
Rothberg MB; Rose DN
Am J Med; 2005 Jan; 118(1):68-77. PubMed ID: 15639212
[TBL] [Abstract][Full Text] [Related]
9. Economic impact of influenza vaccination in preschool children.
Cohen GM; Nettleman MD
Pediatrics; 2000 Nov; 106(5):973-6. PubMed ID: 11061762
[TBL] [Abstract][Full Text] [Related]
10. Economic analysis of influenza vaccination and antiviral treatment for healthy working adults.
Lee PY; Matchar DB; Clements DA; Huber J; Hamilton JD; Peterson ED
Ann Intern Med; 2002 Aug; 137(4):225-31. PubMed ID: 12186512
[TBL] [Abstract][Full Text] [Related]
11. Non-traditional settings for influenza vaccination of adults: costs and cost effectiveness.
Prosser LA; O'Brien MA; Molinari NA; Hohman KH; Nichol KL; Messonnier ML; Lieu TA
Pharmacoeconomics; 2008; 26(2):163-78. PubMed ID: 18198935
[TBL] [Abstract][Full Text] [Related]
12. Cost-benefit analysis of in-hospital influenza vaccination of postpartum women.
Ding Y; Zangwill KM; Hay JW; Allred NJ; Yeh SH
Obstet Gynecol; 2012 Feb; 119(2 Pt 1):306-14. PubMed ID: 22270282
[TBL] [Abstract][Full Text] [Related]
13. Cost-benefit analysis of a national influenza vaccination program in preventing hospitalisation costs in Australian adults aged 50-64 years old.
Raj SM; Chughtai AA; Sharma A; Tan TC; MacIntyre CR
Vaccine; 2019 Sep; 37(40):5979-5985. PubMed ID: 31473001
[TBL] [Abstract][Full Text] [Related]
14. French economic evaluations of influenza and influenza vaccination.
Levy E
Pharmacoeconomics; 1996; 9 Suppl 3():62-6. PubMed ID: 10160489
[TBL] [Abstract][Full Text] [Related]
15. Cost-Effectiveness of Routine Childhood Vaccination Against Seasonal Influenza in Germany.
Scholz SM; Weidemann F; Damm O; Ultsch B; Greiner W; Wichmann O
Value Health; 2021 Jan; 24(1):32-40. PubMed ID: 33431151
[TBL] [Abstract][Full Text] [Related]
16. School-Based Influenza Vaccination: Health and Economic Impact of Maine's 2009 Influenza Vaccination Program.
Basurto-Dávila R; Meltzer MI; Mills DA; Beeler Asay GR; Cho BH; Graitcer SB; Dube NL; Thompson MG; Patel SA; Peasah SK; Ferdinands JM; Gargiullo P; Messonnier M; Shay DK
Health Serv Res; 2017 Dec; 52 Suppl 2(Suppl 2):2307-2330. PubMed ID: 29130266
[TBL] [Abstract][Full Text] [Related]
17. Influenza vaccination and absenteeism among healthy working adults: a cost-benefit analysis.
Ferro A; Bordin P; Benacchio L; Fornasiero F; Bressan V; Tralli V; Moretti F; Majori S
Ann Ig; 2020; 32(3):234-244. PubMed ID: 32266361
[TBL] [Abstract][Full Text] [Related]
18. Household-based costs and benefits of vaccinating healthy children in daycare against influenza virus: results from a pilot study.
Pisu M; Meltzer MI; Hurwitz ES; Haber M
Pharmacoeconomics; 2005; 23(1):55-67. PubMed ID: 15693728
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.
Luce BR; Nichol KL; Belshe RB; Frick KD; Li SX; Boscoe A; Rousculp MD; Mahadevia PJ
Vaccine; 2008 Jun; 26(23):2841-8. PubMed ID: 18462851
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children.
Luce BR; Zangwill KM; Palmer CS; Mendelman PM; Yan L; Wolff MC; Cho I; Marcy SM; Iacuzio D; Belshe RB
Pediatrics; 2001 Aug; 108(2):E24. PubMed ID: 11483834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
